-
Track & Monitor
Innovation in Insurance: Medical event scoring
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the insurance industry’s Medical event scoring segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Track & Monitor
Innovation in Pharmaceuticals: Nucleoside chemical synthesis
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s Nucleoside chemical synthesis segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Track & Monitor
Genomics in Healthcare: Molecular Diagnosis Biomarkers
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Cloud in Healthcare: Point-of-Care Molecular Diagnostics
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Internet of Things in Healthcare: Point-of-Care Molecular Diagnostics
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Artificial Intelligence in Healthcare: Health Insurance Risk Analysis
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Product Insights
Specific Proteins Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Specific Proteins are reagents and test kits that are used to quantify and detect protein molecules from bodily fluids. The Specific Proteins pipeline market research report provides comprehensive information about the Specific Proteins pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Mycobacterium Tuberculosis Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Traditional diagnosis of Mycobacterial infections depends upon smear positivity in sputum samples, culture, and chest radiography. For rapid diagnosis, polymerase chain reaction (PCR), immune-based assays such as enzyme-linked immunosorbent assay (ELISA), skin patch test, and rapid culture systems are performed. The Mycobacterium tuberculosis tests pipeline market research report provides comprehensive information about the Mycobacterium tuberculosis tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Reproductive Hormones and Proteins Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Reproductive hormones and proteins assist in the control and regulation of physiological processes including metabolism, reproduction, and growth and development. They are secreted either from endocrine glands or from organs with secondary endocrine function (such as the pancreas, liver, kidneys, and gonads) and affect the health and behavior of both males and females. GlobalData's Medical Devices sector report, “Reproductive Hormones and Proteins Tests - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Reproductive Hormones and Proteins Tests...
-
Product Insights
Diabetes Assays – Medical Devices Pipeline Assessment, 2020
Diabetes assay are used to measure glucose levels in patient’s sample. This segment comprises of C-peptide assays, glycated hemoglobin (HbA1c) Assays, Insulin assays and other diabetes assays. GlobalData's Medical Devices sector report, “Diabetes Assays-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Diabetes Assays pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Diabetes Assays Pipeline Assessment report provides key information and data related...